06.10.15
SuperSonic Imagine has beefed up its supervisory board with the appointment of a vice chairman.
The company recently announced that Michael Brock, former CEO of Danish ultrasound technology developer BK Medical (now Analogic Corporation), will serve on the board. He has been CEO of MB4Advice (a Denmark firm) since January 2012.
“We are pleased to welcome Michael Brock to the board of SuperSonic Imagine. Michael’s deep expertise in commercializing innovative solutions in healthcare will be of great value to our global expansion strategy,” said Tom Egelund, executive vice president and chief operating officer of SuperSonic Imagine.
As an additional change, Bernard Daugeras of Auriga Partners has stepped down from the board. Auriga Partners was the first fund to invest in SuperSonic Imagine in August 2005. The organization participated in each financing round since inception and also invested at the initial public offering. Auriga remains a significant shareholder.
“I want to thank Auriga and in particular Bernard Daugeras for the trust and support provided over the past 10 years for SuperSonic Imagine. Bernard immediately understood the disruptive nature of our technology and the clinical benefits that could follow,” said Jacques Souquet, president of SuperSonic's executive committee and one of its founding members.
In addition to his new role at SuperSonic Imagine, Brock also serves as board chairman of Omni-Drive, DDD Diagnostic and Solum Group; and a board member of Floating Power Plant and Ibsen Photonics. He also serves as a board member and consultant to Brunata, and is working board chairman at Urodan Aps.
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine specializes in medical imaging. The company designs, develops and markets Aixplorer, an ultrasound system with an UltraFast platform that can acquire images 200 times faster than conventional ultrasound systems. The company claims Aixplorer is the only system that can image two types of waves: ultrasound waves, which ensure excellent image quality, and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner.
The company recently announced that Michael Brock, former CEO of Danish ultrasound technology developer BK Medical (now Analogic Corporation), will serve on the board. He has been CEO of MB4Advice (a Denmark firm) since January 2012.
“We are pleased to welcome Michael Brock to the board of SuperSonic Imagine. Michael’s deep expertise in commercializing innovative solutions in healthcare will be of great value to our global expansion strategy,” said Tom Egelund, executive vice president and chief operating officer of SuperSonic Imagine.
As an additional change, Bernard Daugeras of Auriga Partners has stepped down from the board. Auriga Partners was the first fund to invest in SuperSonic Imagine in August 2005. The organization participated in each financing round since inception and also invested at the initial public offering. Auriga remains a significant shareholder.
“I want to thank Auriga and in particular Bernard Daugeras for the trust and support provided over the past 10 years for SuperSonic Imagine. Bernard immediately understood the disruptive nature of our technology and the clinical benefits that could follow,” said Jacques Souquet, president of SuperSonic's executive committee and one of its founding members.
In addition to his new role at SuperSonic Imagine, Brock also serves as board chairman of Omni-Drive, DDD Diagnostic and Solum Group; and a board member of Floating Power Plant and Ibsen Photonics. He also serves as a board member and consultant to Brunata, and is working board chairman at Urodan Aps.
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine specializes in medical imaging. The company designs, develops and markets Aixplorer, an ultrasound system with an UltraFast platform that can acquire images 200 times faster than conventional ultrasound systems. The company claims Aixplorer is the only system that can image two types of waves: ultrasound waves, which ensure excellent image quality, and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner.